Medical Affairs Consultant

• Dec 2022 - Present

Sr. Director, Field Medical

• Jun 2022 - Nov 2022

Actively contribute to National FMA strategic and operational plans as key collaborator delivering on overall goals and strategy for Medical Affairs. Deliver tactical and operational support by establishing and growing scientific exchange with national Hem/Onc KOLs. Translating complex scientific concepts into clear concise presentations with key stakeholders. Assessed territory mapping and FTEs of hiring 1st wave of MSLs. Novel oral; IRAK4 inhibitor (Emavusertib, CA-4948) and mAb, VISTA… Show more Actively contribute to National FMA strategic and operational plans as key collaborator delivering on overall goals and strategy for Medical Affairs. Deliver tactical and operational support by establishing and growing scientific exchange with national Hem/Onc KOLs. Translating complex scientific concepts into clear concise presentations with key stakeholders. Assessed territory mapping and FTEs of hiring 1st wave of MSLs. Novel oral; IRAK4 inhibitor (Emavusertib, CA-4948) and mAb, VISTA antagonist (CI-8993). Support three, Phase 1 clinical trials across numerous leukemia, lymphoma and solid tumor indications. Show less Actively contribute to National FMA strategic and operational plans as key collaborator delivering on overall goals and strategy for Medical Affairs. Deliver tactical and operational support by establishing and growing scientific exchange with national Hem/Onc KOLs. Translating complex scientific concepts into clear concise presentations with key stakeholders. Assessed territory mapping and FTEs of hiring 1st wave of MSLs. Novel oral; IRAK4 inhibitor (Emavusertib, CA-4948) and mAb, VISTA… Show more Actively contribute to National FMA strategic and operational plans as key collaborator delivering on overall goals and strategy for Medical Affairs. Deliver tactical and operational support by establishing and growing scientific exchange with national Hem/Onc KOLs. Translating complex scientific concepts into clear concise presentations with key stakeholders. Assessed territory mapping and FTEs of hiring 1st wave of MSLs. Novel oral; IRAK4 inhibitor (Emavusertib, CA-4948) and mAb, VISTA antagonist (CI-8993). Support three, Phase 1 clinical trials across numerous leukemia, lymphoma and solid tumor indications. Show less

Sr. Medical Science Liaison

• Jun 2021 - Jun 2022

Executive Medical Science Liaison

• Dec 2020 - Jun 2021

MSL Immuno/Hem T-cells ♦ Clinical Trial Recruitment♦ Engage KOLs/Education ♦Prospect Naive Geography

• Jan 2018 - Jun 2021

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with Epstein-Barr Virus (EBV+) associated malignancies and diseases. The platform utilizes T‑Cells from healthy donors, specifically targeting cancerous or diseased cells in patients without affecting normal cells. Our investigational, off-the-shelf T‑cell libraries are intended for rapid delivery from inventory to patients.

Medical Science Liaison Hem/Onc ►ImmunoHematology CAR T ♦ Awarded Leader ♦ Engaging KOLs

• Sep 2016 - Jan 2018

Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to selectively target and kill cancer cells. Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies. We are on… Show more Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to selectively target and kill cancer cells. Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies. We are on a rapid growth trajectory and have a highly energized and accomplished team. Medical Science Liaisons (MSLs) are field-based and report to a Regional Lead of MSLs within the Medical Affairs (MA) department. MSLs are scientifically trained professionals with strong clinical backgrounds who must have excellent communication skills. They are responsible for identifying, developing, and managing relationships with current and future hematology thought leaders in academic and community practices. Show less Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to selectively target and kill cancer cells. Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies. We are on… Show more Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to selectively target and kill cancer cells. Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies. We are on a rapid growth trajectory and have a highly energized and accomplished team. Medical Science Liaisons (MSLs) are field-based and report to a Regional Lead of MSLs within the Medical Affairs (MA) department. MSLs are scientifically trained professionals with strong clinical backgrounds who must have excellent communication skills. They are responsible for identifying, developing, and managing relationships with current and future hematology thought leaders in academic and community practices. Show less

Medical Science Liaison, Hem/Onc ►Robust KOL Education Experience ♦ Proven Leader ♦ Engaging KOLs

• Mar 2016 - Sep 2016

As a Regional Medical Science Liaison, I am responsible for the 9 approved Amgen Oncology/Hematology products and pipeline. The Regional Medical Science Liaison interacts with Oncology/Hematology Healthcare Decision Makers to communicate and advance the scientific platform as aligned with corporate goals and objectives. The RMSL is an integral position in assuring accurate, clear and valued information regarding our scientific platform is communicated to multiple levels within the medical… Show more As a Regional Medical Science Liaison, I am responsible for the 9 approved Amgen Oncology/Hematology products and pipeline. The Regional Medical Science Liaison interacts with Oncology/Hematology Healthcare Decision Makers to communicate and advance the scientific platform as aligned with corporate goals and objectives. The RMSL is an integral position in assuring accurate, clear and valued information regarding our scientific platform is communicated to multiple levels within the medical community. The RMSL communicates complex cutting-edge scientific information and research concepts to healthcare decision makers including but not limited to those at Academic Medical Centers. The role also includes clinical and pharmacoeconomic value discussions with formulary decision makers. The Regional Medical Science Liaison is further responsible for training members of company speakers’ bureau to ensure they are updated on medical science information. The RMSL provides feedback based on field interactions and scientific support consistent with corporate goals and objectives. Importantly, the Regional Medical Science Liaison supports company and investigator sponsored research within Oncology/Hematology. Show less As a Regional Medical Science Liaison, I am responsible for the 9 approved Amgen Oncology/Hematology products and pipeline. The Regional Medical Science Liaison interacts with Oncology/Hematology Healthcare Decision Makers to communicate and advance the scientific platform as aligned with corporate goals and objectives. The RMSL is an integral position in assuring accurate, clear and valued information regarding our scientific platform is communicated to multiple levels within the medical… Show more As a Regional Medical Science Liaison, I am responsible for the 9 approved Amgen Oncology/Hematology products and pipeline. The Regional Medical Science Liaison interacts with Oncology/Hematology Healthcare Decision Makers to communicate and advance the scientific platform as aligned with corporate goals and objectives. The RMSL is an integral position in assuring accurate, clear and valued information regarding our scientific platform is communicated to multiple levels within the medical community. The RMSL communicates complex cutting-edge scientific information and research concepts to healthcare decision makers including but not limited to those at Academic Medical Centers. The role also includes clinical and pharmacoeconomic value discussions with formulary decision makers. The Regional Medical Science Liaison is further responsible for training members of company speakers’ bureau to ensure they are updated on medical science information. The RMSL provides feedback based on field interactions and scientific support consistent with corporate goals and objectives. Importantly, the Regional Medical Science Liaison supports company and investigator sponsored research within Oncology/Hematology. Show less

Regional Sales Manager, Oncology ►Sales Force Coach ♦ Product Launches ♦ Sales Force Expansion

• Jun 2012 - Oct 2015

Chosen to lead and manage a team of nine Oncology Sales Professionals across a 15-state region, with a focus upon promoting successful representatives and strengthening areas of necessary improvement. Executed staggered hiring, training, development, and coaching initiatives for multiple regional sales forces. Demonstrated robust leadership through multiple Xtandi prostate cancer launches in Medical Oncology and Urology. With a ten year selling history of Tarceva, responsible to lead training… Show more Chosen to lead and manage a team of nine Oncology Sales Professionals across a 15-state region, with a focus upon promoting successful representatives and strengthening areas of necessary improvement. Executed staggered hiring, training, development, and coaching initiatives for multiple regional sales forces. Demonstrated robust leadership through multiple Xtandi prostate cancer launches in Medical Oncology and Urology. With a ten year selling history of Tarceva, responsible to lead training of new reps for Tarceva in Non Small Cell Lung Cancer (NSCLC). Show less Chosen to lead and manage a team of nine Oncology Sales Professionals across a 15-state region, with a focus upon promoting successful representatives and strengthening areas of necessary improvement. Executed staggered hiring, training, development, and coaching initiatives for multiple regional sales forces. Demonstrated robust leadership through multiple Xtandi prostate cancer launches in Medical Oncology and Urology. With a ten year selling history of Tarceva, responsible to lead training… Show more Chosen to lead and manage a team of nine Oncology Sales Professionals across a 15-state region, with a focus upon promoting successful representatives and strengthening areas of necessary improvement. Executed staggered hiring, training, development, and coaching initiatives for multiple regional sales forces. Demonstrated robust leadership through multiple Xtandi prostate cancer launches in Medical Oncology and Urology. With a ten year selling history of Tarceva, responsible to lead training of new reps for Tarceva in Non Small Cell Lung Cancer (NSCLC). Show less

Oncology Sales Specialist ► Top Performer ♦ Workshop Developer & Trainer ♦ Sales Strategies

• Jun 2003 - May 2012

Selected among start up sales force of 27 team members, Successfully promoted within disease states of NSCLC (Tarceva), Pancreatic cancer, NHL (Novantrone), HRPC, ANLL, and Oral Mucositis (Gelclair). Served as a 4 year regional field trainer conducting ride-a-longs, detailed feedback and written evaluations. Led monthly journal clubs, study analyses, & scientific discussions. Developed learning & training associated with launching new business & products. High achievement as President's Club… Show more Selected among start up sales force of 27 team members, Successfully promoted within disease states of NSCLC (Tarceva), Pancreatic cancer, NHL (Novantrone), HRPC, ANLL, and Oral Mucositis (Gelclair). Served as a 4 year regional field trainer conducting ride-a-longs, detailed feedback and written evaluations. Led monthly journal clubs, study analyses, & scientific discussions. Developed learning & training associated with launching new business & products. High achievement as President's Club and Sales Excellence Award Winner. Show less Selected among start up sales force of 27 team members, Successfully promoted within disease states of NSCLC (Tarceva), Pancreatic cancer, NHL (Novantrone), HRPC, ANLL, and Oral Mucositis (Gelclair). Served as a 4 year regional field trainer conducting ride-a-longs, detailed feedback and written evaluations. Led monthly journal clubs, study analyses, & scientific discussions. Developed learning & training associated with launching new business & products. High achievement as President's Club… Show more Selected among start up sales force of 27 team members, Successfully promoted within disease states of NSCLC (Tarceva), Pancreatic cancer, NHL (Novantrone), HRPC, ANLL, and Oral Mucositis (Gelclair). Served as a 4 year regional field trainer conducting ride-a-longs, detailed feedback and written evaluations. Led monthly journal clubs, study analyses, & scientific discussions. Developed learning & training associated with launching new business & products. High achievement as President's Club and Sales Excellence Award Winner. Show less

Senior Sales Specialist

• 1999 - 2003

Lilly, a leading innovation-driven corporation, develops a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Lilly, a leading innovation-driven corporation, develops a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.